Artemis SmartGARP Global Equity Fund update

Raheel Altaf, manager of the Artemis SmartGARP Global Equity Fund, reports on the fund over the quarter to 30 September 2024.

Raheel Altaf

Source for all information: Artemis as at 30 September 2024, unless otherwise stated.

  • Over the quarter the fund returned -3.3% in sterling terms vs the MSCI AC World index's return of 0.5%.
  • Year to date the fund has returned 13.7% vs the index's 12.8%, resulting in top quartile performance despite significant underweight to the US and to the so-called Magnificent 7. 
  • Value bias in the fund remains substantial, 47% discount to MSCI ACWI…
  • …with market level quality and growth characteristics

12m forward P/E ROE Dividend yield
Fund 9.5x 14.4% 3.7%
Benchmark 17.9x 14.6% 2.0%
Relative -47x -0.2% +1.7%
Source: Artemis, Bloomberg, MSCI as at 30 September 2024. ROE is a blend of 3-year trailing and 2-year forward.

Performance – muted returns mask summer months packed with volatility and policy moves

Global equities ended the quarter up 0.5%, taking year to date performance to 12.8% (in sterling terms). There was considerable volatility over the three months. In July, earnings weakness in some of the index’s largest constituents cast doubt on the sustainability of their share prices. This was accompanied by weaker economic data which reignited fears of a recession, and the unwind of the Yen carry trade (whereby investors had borrowed in Japanese Yen to invest in higher-yielding assets) as the Bank of Japan raised interest rates by 25bps. The unwind, coupled with global growth fears, led to the Japanese TOPIX index  shedding almost 13% in a single day in August. 

Markets recovered remarkably quickly from this turmoil, with the Federal Reserve going on to deliver a 50bp rate cut. Outside of the US, China announced significant stimulus targeting both the supply and demand side of the equation – the latter having been the key component that the market had been looking for. This prompted a rally in Chinese equities as international investors were drawn back to the region. 

Three months Six months One year Three years Since launch
Artemis SmartGARP Global Equity Fund -3.3% 0.7% 14.0% 18.3% 291.0%
MSCI World NR GBP 0.5% 3.3% 19.9% 26.9% 387.9%
IA Global Average 0.2% 1.2% 16.4% 14.0% 294.3%

Past performance is not a guide to the future. Source: Lipper Limited as at 30 September 2024 for class I accumulation GBP. All figures show total returns with dividends and/or income reinvested, net of all charges. Performance does not take account of any costs incurred when investors buy or sell the fund. Returns may vary as a result of currency fluctuations if the investor's currency is different to that of the class. This class may have charges or a hedging approach different from those in the IA sector benchmark. 

Attribution

The fund underperformed the index returning -3.3% vs the index's 0.5%. By country, our largest detractors were in China and the US. The former were energy holdings such as PetroChina, CGN Power, and CNOOC, which were dragged down by declining oil prices. Our US exposure also proved to be a headwind to fund performance. Dell and Qualcomm, two semiconductor-related companies, underperformed due to broader concerns around the sustainability of AI expenditure.

On the positive side, a broad range of companies partially offset some of the weakness in other areas. Comfort Systems (US, industrials), United Lands (Hong Kong, pharmaceuticals), Unum (US, insurance), and Tenet Healthcare (US, healthcare) all helped performance.

Activity – China recovery, energy into healthcare.

Additions:

  • Healthcare: HCA Healthcare, Tenet, Teva
  • China recovery: Alibaba, Geely

Sales:

  • Oil & Gas: Repsol, Total, Exxon
  • Deteriorating fundamentals: Associated British Foods, Merck

Deeply discounted with attractive growth and quality metrics

The minor changes we made over the quarter leave the fund's high-level characteristics unchanged. It has a significant valuation discount to the market while maintaining attractive growth and income characteristics. At a regional level, little has changed. We remain heavily overweight to emerging markets and Europe, with a substantial underweight in the US (47% of the fund vs 67% Index). At a sector level we remain overweight in banks, food & beverages, and insurance. Our main underweights are to technology, financial services, and industrial goods.

We have slightly reduced our exposure to the energy sector and increased our exposure to healthcare. In part this is because there are near-term headwinds to the oil price, but also because there are attractive healthcare companies in the US that are seeing upwards revisions to profit forecasts.

We believe the fund to be not only a core global equity holding, but also an attractive addition to portfolios as a diversifier away from some of more growth-oriented areas of the market that investors remain concentrated in.

Our focus on fundamentals continues

We continue to focus on the fundamental performance of businesses and where that performance is not yet fully reflected in the share price. As we move through these volatile periods, distortions occur in equity markets caused by short termism. A strategy that has a longer-term time horizon, and one that is designed to profit from these biases should stand the test of time.

A word on China

Within the fund we have been overweight the country for some time, simply because it is home to a plethora of businesses displaying attractive fundamentals and trading at deeply discounted valuations. This has required a good deal of patience, but we feel the recent policy announcements by the government should reward us over the coming months for having conviction in our process.

Benchmarks: MSCI AC World NR; A widely-used indicator of the performance of global stockmarkets, in which the fund invests. IA Global NR; A group of other asset managers’ funds that invest in similar asset types as this fund, collated by the Investment Association. These benchmarks act as ‘comparator benchmarks’ against which the fund’s performance can be compared. Management of the fund is not restricted by these benchmarks.

Raheel Altaf

Manages:

‘Global emerging markets equity‘, 'Global equity' strategies

Raheel joined Artemis in 2014 and has managed Artemis‘ ‘global emerging markets equity‘ and ‘global equity’ strategies since launch in April 2015 and since April 2022, respectively.

View Profile

Investment in a fund concerns the acquisition of units/shares in the fund and not in the underlying assets of the fund.

Reference to specific shares or companies should not be taken as advice or a recommendation to invest in them.

For information on sustainability-related aspects of a fund, visit the relevant fund page on this website.

For information about Artemis’ fund structures and registration status, visit artemisfunds.com/fund-structures

Any research and analysis in this communication has been obtained by Artemis for its own use. Although this communication is based on sources of information that Artemis believes to be reliable, no guarantee is given as to its accuracy or completeness.

Any statements are based on Artemis’ current opinions and are subject to change without notice. They are not intended to provide investment advice and should not be construed as a recommendation.

Third parties (including FTSE and Morningstar) whose data may be included in this document do not accept any liability for errors or omissions. For information, visit artemisfunds.com/third-party-data.

Important information
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.